• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

WT1对多发性硬化症中干扰素-β - 维生素D关联的调节作用。

Modulating effects of WT1 on interferon-β-vitamin D association in MS.

作者信息

Lin R, Taylor B V, Charlesworth J, van der Mei I, Blizzard L, Stewart N, Ponsonby A-L, Dwyer T, Pittas F, Simpson S

机构信息

Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tas., Australia; Guangxi Center for Disease Prevention and Control, Nanning, China.

出版信息

Acta Neurol Scand. 2015 Apr;131(4):231-9. doi: 10.1111/ane.12315. Epub 2014 Oct 14.

DOI:10.1111/ane.12315
PMID:25312909
Abstract

OBJECTIVE

To investigate whether those genes involved in the vitamin D pathway modulate the relationship between 25-hydroxyvitamin D (25(OH)D) and IFN-β, the relationship between IFN-β and sun in predicting 25(OH)D, and the interaction between IFN-β and 25(OH)D in modulating relapse risk in patients with MS.

METHODS

Prospective cohort study of 169 participants with MS and genotype data followed 2002-2005. Gene-IFN-β and gene-IFN-β-sun interactions predicting 25(OH)D evaluated by multilevel mixed-effects linear regression. Gene-IFN-β interactions with 25(OH)D in modulating in relapse risk assessed using survival analysis.

RESULTS

The cohort was 71.6% female and of mean age 47.8. Two-independent intronic genotyped SNPs (rs10767935 and rs5030244) in WT1 significantly modified the IFN-β-25(OH)D association after adjustment (P(interaction) = 0.001, 0.0002; P(adj) = 0.003, 0.006, respectively). There was a marked difference in the interaction between self-reported sun exposure and IFN-β in predicting 25(OH)D by level of rs10767935, although this did not reach statistical significance. No SNPs modified the interaction between IFN-β and 25(OH)D in predicting relapse.

CONCLUSIONS

We have demonstrated that two-independent SNPs (rs10767935 and rs5030244) in WT1 modified the IFN-β-25(OH)D association in patients with MS. Some evidence was shown for a difference in the sun-IFN-β-25(OH)D association by level of rs10767935. These findings indicate that WT1 variants may play a role in altering the effects of IFN-β on vitamin D in MS.

摘要

目的

研究参与维生素D途径的那些基因是否会调节25-羟基维生素D(25(OH)D)与干扰素-β(IFN-β)之间的关系、IFN-β与阳光在预测25(OH)D方面的关系,以及IFN-β与25(OH)D在调节多发性硬化症(MS)患者复发风险中的相互作用。

方法

对169名患有MS且有基因分型数据的参与者进行2002 - 2005年的前瞻性队列研究。通过多级混合效应线性回归评估基因 - IFN-β以及基因 - IFN-β - 阳光之间预测25(OH)D的相互作用。使用生存分析评估基因 - IFN-β与25(OH)D在调节复发风险中的相互作用。

结果

该队列中女性占71.6%,平均年龄47.8岁。WT1基因中两个独立的内含子基因分型单核苷酸多态性(SNP,rs10767935和rs5030244)在调整后显著改变了IFN-β - 25(OH)D的关联(交互作用P值分别为0.001、0.0002;调整后P值分别为0.003、0.006)。根据rs10767935水平,自我报告的阳光暴露与IFN-β在预测25(OH)D方面的相互作用存在显著差异,尽管未达到统计学显著性。在预测复发方面,没有SNP改变IFN-β与25(OH)D之间的相互作用。

结论

我们已经证明,WT1基因中的两个独立SNP(rs10767935和rs5030244)改变了MS患者中IFN-β - 25(OH)D的关联。有一些证据表明,根据rs10767935水平,阳光 - IFN-β - 25(OH)D的关联存在差异。这些发现表明,WT1基因变体可能在改变IFN-β对MS中维生素D的作用方面发挥作用。

相似文献

1
Modulating effects of WT1 on interferon-β-vitamin D association in MS.WT1对多发性硬化症中干扰素-β - 维生素D关联的调节作用。
Acta Neurol Scand. 2015 Apr;131(4):231-9. doi: 10.1111/ane.12315. Epub 2014 Oct 14.
2
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.WT1与干扰素-β-维生素D在多发性硬化症中的关联:一项纵向研究。
Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448. Epub 2015 Jun 2.
3
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.干扰素-β 和血清 25-羟维生素 D 相互作用调节 MS 的复发风险。
Neurology. 2012 Jul 17;79(3):254-60. doi: 10.1212/WNL.0b013e31825fded9. Epub 2012 Jun 13.
4
Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.PKC 家族基因对血清维生素 D 与多发性硬化症复发关系的新调节作用。
J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):399-404. doi: 10.1136/jnnp-2013-305245. Epub 2013 Jul 18.
5
Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.多发性硬化症风险相关 SNP 与复发和残疾的关联——一项前瞻性队列研究。
Mult Scler. 2014 Mar;20(3):313-21. doi: 10.1177/1352458513496882. Epub 2013 Jul 25.
6
Multiple sclerosis: effects of IFN-β treatment on vitamin D levels in multiple sclerosis are modified by genetic variants.多发性硬化症:干扰素-β治疗对多发性硬化症患者维生素D水平的影响会因基因变异而改变。
Nat Rev Neurol. 2014 Dec;10(12):672. doi: 10.1038/nrneurol.2014.210. Epub 2014 Nov 4.
7
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.刺激 PBMC 产生的 IFN-γ 和 TNF-α 与多发性硬化症的复发风险改变有关:来自前瞻性队列研究的结果。
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):200-7. doi: 10.1136/jnnp-2013-307336. Epub 2014 May 1.
8
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.维生素 D 与多发性硬化症在干扰素-β治疗前后的疾病活动。
Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13.
9
A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.一项关于血清25-羟基维生素D和完整甲状旁腺激素水平的纵向研究表明了维生素D和钙稳态调节在多发性硬化症中的重要性。
J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):152-7. doi: 10.1136/jnnp.2006.105320. Epub 2007 Jun 19.
10
Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients.干扰素β治疗的多发性硬化症患者中MXA单核苷酸多态性的药物遗传学
J Neuroimmunol. 2007 Jan;182(1-2):236-9. doi: 10.1016/j.jneuroim.2006.10.011. Epub 2006 Nov 27.

引用本文的文献

1
The impact of genetic variants related to vitamin D and autoimmunity: A systematic review.与维生素D和自身免疫相关的基因变异的影响:一项系统综述。
Heliyon. 2024 Mar 21;10(7):e27700. doi: 10.1016/j.heliyon.2024.e27700. eCollection 2024 Apr 15.
2
Imprinted Genes and Multiple Sclerosis: What Do We Know?印记基因与多发性硬化症:我们了解多少?
Int J Mol Sci. 2021 Jan 29;22(3):1346. doi: 10.3390/ijms22031346.
3
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough.维生素 D 补充治疗中枢神经系统脱髓鞘疾病——够了!
Int J Mol Sci. 2019 Jan 8;20(1):218. doi: 10.3390/ijms20010218.
4
Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.维生素 D 受体的基因组效应:维生素 D、免疫细胞和多发性硬化症之间的潜在联系。
Front Immunol. 2018 Mar 12;9:477. doi: 10.3389/fimmu.2018.00477. eCollection 2018.
5
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.维生素D状态不影响多发性硬化症患者三年随访期间的残疾进展。
PLoS One. 2016 Jun 8;11(6):e0156122. doi: 10.1371/journal.pone.0156122. eCollection 2016.
6
A rare variant at 11p13 is associated with tuberculosis susceptibility in the Han Chinese population.11号染色体短臂13区的一个罕见变异与中国汉族人群的结核病易感性相关。
Sci Rep. 2016 Apr 1;6:24016. doi: 10.1038/srep24016.
7
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.IFN-β1a 对多发性硬化症患者炎症小体和凋亡相关斑点样蛋白表达的影响。
Mol Neurobiol. 2017 May;54(4):3031-3037. doi: 10.1007/s12035-016-9864-8. Epub 2016 Mar 31.
8
Multiple sclerosis: effects of IFN-β treatment on vitamin D levels in multiple sclerosis are modified by genetic variants.多发性硬化症:干扰素-β治疗对多发性硬化症患者维生素D水平的影响会因基因变异而改变。
Nat Rev Neurol. 2014 Dec;10(12):672. doi: 10.1038/nrneurol.2014.210. Epub 2014 Nov 4.